Ribosomal protein L7 pseudogene 60 (RPL7P60)

RPL7P60 is a processed pseudogene generated from the ribosomal protein L7 gene (RPL7)[2][4]. Pseudogenes typically arise from duplication or retrotransposition events and do not produce functional proteins. Human ribosomal protein genes, such as RPL7, commonly have multiple pseudogenes dispersed throughout the genome[4]. RPL7P60 itself does not play a role in ribosome assembly, protein synthesis, or disease mechanisms, nor is it considered a therapeutic target or biomarker. Key points for context: - Pseudogene status: RPL7P60 is not a receptor, enzyme, transporter, functional protein, or target; it does not encode a protein product and lacks biological activity[2][4]. - Related protein (RPL7): The functional ribosomal protein L7 (RPL7) is a component of the large (60S) ribosomal subunit and participates in protein synthesis. RPL7 has regulatory and structural roles, but RPL7P60 does not share these properties[1][5][6]. - Therapeutic relevance: As a pseudogene, RPL7P60 is not used as a drug target, is not associated with drug interactions or mechanisms of action, and has no reported roles in disease. If you are seeking information on the functional ribosomal protein L7 or its gene, refer to RPL7 rather than RPL7P60.

Other names

RPL7P60